| Dr Sobhan Kodali, MD | |
|
1469 8th Ave, Bethlehem, PA 18018-2256 | |
| (610) 419-7800 | |
| (610) 419-7810 |
| Full Name | Dr Sobhan Kodali |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 20 Years |
| Location | 1469 8th Ave, Bethlehem, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396047700 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD438915 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Miners Memorial Hospital | Coaldale, PA | Hospital |
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| St Luke's Hospital - Anderson Campus | Easton, PA | Hospital |
| St Luke's Hospital - Easton Campus | Easton, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Luke's Physician Group Inc | 6709798333 | 1739 |
News Archive
High levels of daily stress appear to result in a lower risk of developing breast cancer for the first time, says a study in the British Medical Journal.
Researchers in the United States and India have presented the first known evidence that the rollout of coronavirus disease 2019 (COVID-19) vaccination is restricting the evolutionary and immune escape pathways accessible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Eisai announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of Fycompa (perampanel) as an adjunctive treatment of partial-onset seizures, with or without secondarily generalised seizures, in patients with epilepsy aged 12 years and older.
After aggregating and mining physician responses to ePromotion campaigns spanning more than 115 brands, 64 therapeutic conditions and 30 specialties, Lathian Health today announced the availability of its proprietary longitudinal data assets to life science companies.
A new study describes the structure of a crucial enzyme present in SARS-CoV-2.
› Verified 1 days ago
| Entity Name | St Luke's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508874538 PECOS PAC ID: 0648189688 Enrollment ID: O20031106000233 |
News Archive
High levels of daily stress appear to result in a lower risk of developing breast cancer for the first time, says a study in the British Medical Journal.
Researchers in the United States and India have presented the first known evidence that the rollout of coronavirus disease 2019 (COVID-19) vaccination is restricting the evolutionary and immune escape pathways accessible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Eisai announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of Fycompa (perampanel) as an adjunctive treatment of partial-onset seizures, with or without secondarily generalised seizures, in patients with epilepsy aged 12 years and older.
After aggregating and mining physician responses to ePromotion campaigns spanning more than 115 brands, 64 therapeutic conditions and 30 specialties, Lathian Health today announced the availability of its proprietary longitudinal data assets to life science companies.
A new study describes the structure of a crucial enzyme present in SARS-CoV-2.
› Verified 1 days ago
| Entity Name | St Lukes Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700984622 PECOS PAC ID: 6709798333 Enrollment ID: O20040226000062 |
News Archive
High levels of daily stress appear to result in a lower risk of developing breast cancer for the first time, says a study in the British Medical Journal.
Researchers in the United States and India have presented the first known evidence that the rollout of coronavirus disease 2019 (COVID-19) vaccination is restricting the evolutionary and immune escape pathways accessible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Eisai announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of Fycompa (perampanel) as an adjunctive treatment of partial-onset seizures, with or without secondarily generalised seizures, in patients with epilepsy aged 12 years and older.
After aggregating and mining physician responses to ePromotion campaigns spanning more than 115 brands, 64 therapeutic conditions and 30 specialties, Lathian Health today announced the availability of its proprietary longitudinal data assets to life science companies.
A new study describes the structure of a crucial enzyme present in SARS-CoV-2.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sobhan Kodali, MD 1469 8th Ave, Bethlehem, PA 18018-2256 Ph: (610) 419-7800 | Dr Sobhan Kodali, MD 1469 8th Ave, Bethlehem, PA 18018-2256 Ph: (610) 419-7800 |
News Archive
High levels of daily stress appear to result in a lower risk of developing breast cancer for the first time, says a study in the British Medical Journal.
Researchers in the United States and India have presented the first known evidence that the rollout of coronavirus disease 2019 (COVID-19) vaccination is restricting the evolutionary and immune escape pathways accessible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Eisai announced today that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of Fycompa (perampanel) as an adjunctive treatment of partial-onset seizures, with or without secondarily generalised seizures, in patients with epilepsy aged 12 years and older.
After aggregating and mining physician responses to ePromotion campaigns spanning more than 115 brands, 64 therapeutic conditions and 30 specialties, Lathian Health today announced the availability of its proprietary longitudinal data assets to life science companies.
A new study describes the structure of a crucial enzyme present in SARS-CoV-2.
› Verified 1 days ago
Ashokkumar H Gaba, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2649 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-9677 | |
Kathryn Mae Pisarcik, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2545 Schoenersville Rd Fl 2, Bethlehem, PA 18017 Phone: 484-884-9677 Fax: 484-884-9297 | |
Dr. Minh Quang Nguyen, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2300 Highland Ave, Bethlehem, PA 18020 Phone: 610-402-3110 | |
Dr. Jonathan H Munves, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2597 Schoenersville Rd, Suite 302, Bethlehem, PA 18017 Phone: 610-691-6222 Fax: 484-403-4011 | |
Dr. Anna Alina Niewiarowska, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 306 S New St Ste 201, Bethlehem, PA 18015 Phone: 610-866-0113 Fax: 610-974-8589 | |
Gonzalo Pimentel, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-9677 | |
Jeffrey Faidley, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2545 Schoenersville Rd, Bethlehem, PA 18017 Phone: 484-884-9677 |